Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas

Critical Reviews in Oncology/Hematology

Volumn 56, Issue 3, 2005, Pages 353-364

  Bernier, Jacques ^a,d   Pfister, David G ^b   Cooper, Jay S ^c  

^a SAN GIOVANNI HOSPITAL   (Switzerland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MAIMONIDES MEDICAL CENTER   (United States)

^d ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Chemo radiation; Chemotherapy; Head and neck; Radiotherapy; Randomized trials

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN; PLATINUM DERIVATIVE; TIRAPAZAMINE;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GRANULOCYTOPENIA; HEAD AND NECK CARCINOMA; HEMATOLOGIC DISEASE; HUMAN; META ANALYSIS; MUCOSA INFLAMMATION; MYOFIBROSIS; PATIENT COMPLIANCE; PROGNOSIS; RADIATION DOSE; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME; XEROSTOMIA;

EID: 27144469873     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2005.04.010     Document Type: Review

References (72)

1. D.M. Parkin, C.S. Muir, S.L. Whelan, Y.T. Gao, J. Ferlay, and J. Powell Cancer incidence in five continents vol. 6 1992 IARC Lyon
2. M. Al-Sarraf, and M. Hussein Head and neck cancer: present status and future prospects of adjuvant chemotherapy Cancer Invest 13 1995 41 53
3. J.P. Pignon, J. Bourhis, C. Domenge, L. Designe MACH-NC Collaborative Group Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Meta-analysis of chemotherapy on head and neck cancer Lancet 355 9208 2000 949 955
4. G.H. Fletcher, and W. Evers Radiotherapeutic management of surgical recurrences and post-operative residuals in tumors of the head and neck Radiology 95 1970 185 188
5. S. Kramer, R.D. Gelber, and J.B. Snow Combined radiation therapy and surgery in the management of Head and cancer: final report of study 73-03 of the radiation therapy Oncology group Head Neck Surg 10 1987 19 30
6. G.B. Snow, A.A. Annyas, E.A. van Slotten, H. Bartelink, and A.A. Hart Prognostic factors of neck node metastases Clin Otolaryngol 1982 185 192
7. B. Vikram, E.W. Strong, J.P. Shah, and R. Spiro Failure at the primary site following multimodality treatment in advanced head and neck cancer Head Neck Surg 6 1984 720 723
8. J.T. Johnson, E.L. Barnes, E.N. Myers, V.L. Schramm, D. Borochovitz, and B.A. Sigler The extracapsular spread of tumors in cervical node metastasis Arch Otolaryngol 107 1981 725 729
9. HN. Contracts Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program Cancer 60 3 1987 301 311
10. G.E. Laramore, C.B. Scoot, and M. Al-Sarraf Adjuvant chemotherapy for respectable squamous cell carcinoma of the head and neck: report on intergroup study 0034 Int J Radiat Oncol Biol Phys 23 1992 705 713
11. K. Bitter Post-operative chemotherapy versus post-operative cobalt-60 radiation therapy in patients with advanced oral carcinoma Head Neck Surg 3 1981 260 (abs)
12. K.K. Fu, T.L. Phillips, and I.Y. Silverberg Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancers. Update of a Northern California oncology group randomized trial J Clin Oncol 5 1987 1410 1418
13. I.F. Tannock Combined modality treatment with radiotherapy and chemotherapy Radiother Oncol 16 1989 83 101
14. P.M. Stell, and N.S. Rawson Adjuvant chemotherapy in head and neck cancer Br J Cancer 61 1990 779 787
15. A.J. Munro An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer Br J Cancer 71 1995 83 91
16. S. El Sayed, and N. Nelson Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials J Clin Oncol 14 1996 838 847
17. G.P. Browman, D.I. Hodson, R.J. Mackenzie, N. Bestic, and L. Zuraw Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis Head Neck 23 2001 579 589
18. R.M. Byers, G.L. Clayman, and O.M. Guillamondegui Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract Head Neck 14 1992 133 138
19. R.B. Marcus, R.R. Million, and N.J. Cassisi Post-operative irradiation for squamous cell carcinoma of head and neck: analysis of time-dose factors related to control above the clavicles Int J Radiat Oncol Biol Phys 5 1943-1949
20. L. Tupchong, C.B. Scott, and P.H. Blitzer Randomized study of preoperative versus post-operative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03 Int J Radiat Oncol Biol Phys 20 1991 21 28
21. J.T. Shah, A.A. Cendon, H.W. Farr, and E.W. Strong Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and neck Am J Surg 132 1976 1401 1410
22. H. Bartelink, K. Breur, and G. Hart Radiotherapy of lymph node metastases in squamous cell carcinomas of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx Int J Radiat Oncol Biol Phys 8 1982 983 990
23. J.P. Bataini, B. Asselain, and C. Jaulerry A multivariate primary tumor control analysis in 465 patients treated by radical radiotherapy for carcinoma of the tonsillar region: clinical and treatment parameters as prognostic factors Radiother Oncol 14 1989 265 277
24. J. Bernier, and J.P. Bataini Regional outcome in oropharyngeal and pharyngolaryngeal cancers treated with high dose per fraction radiotherapy Analysis of neck disease response in 1646 cases Radiother Oncol 6 1986 87 103
25. T.W. Griffin, T.F. Pajak, and B.W. Gillespie Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck cancer registry Int J Radiat Oncol Biol Phys 10 1984 481 487
26. J.T. Johnson, E.N. Myers, and V.L. Schramm Adjuvant chemotherapy for high risk squamous cell carcinomas of the head and neck J Clin Oncol 5 1987 456 458
27. A. Rossi, R. Molinari, and P. Boracchi Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in loco-regional nasopharyngeal cancer: results of a four-year multicenter randomized study J Clin Oncol 6 1988 1401 1410
28. H. Szpirglas, C.L. Chastang, and J.C. Bertrand Adjuvant treatment of tongue and floor of mouth cancer Cancer Res 68 1978 309 317
29. G.E. Laramore, C.B. Scott, and M. Al Sarraf Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on intergroup study 0034 Int J Radiat Oncol Biol Phys 21 S1 1991 190
30. C. Jacobs, and R. Makuch Efficacy of adjuvant chemotherapy for patients with resectable H&N cancer. A subset analysis of Head and Neck Contract Programs J Clin Oncol 8 1990 838 843
31. L. Dewitt Combined treatment of radiation and cis- diamminedichloroplatinum (II): a review of experimental and clinical data Int J Radiat Oncol Biol Phys 13 1987 403 426
32. E.E. Vokes, and A.M. Awan Weichselbaum RR Radiotherapy with concomitant chemotherapy for head and neck cancer Oncol Clin North AM 5 1991 5753 5767
33. T.G. Wendt The radiochemotherapy of advanced head and neck tumors. What is certain? Strahlenther Onkol 172 1996 409 416
34. D.M. Brizel, M.E. Albers, and S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
35. A.T. Huanq, T.B. Cole, and R. Fishburn Adjuvant chemotherapy after surgery and radiation far stage III and IV H&N cancer Ann Surg 100 1984 195 199
36. J.R. Jacobs, T.F. Pajak, and M. Al Sarraf Chemotherapy following surgery in head and neck cancer Am J Clin Oncol 12 1989 185 189
37. R.E. Haselow, M.G. Marshaw, and M.M. Okin Radiation alone versus radiation plus weekly low-dose cis-platinum in unresectable cancer of the head and neck W.E. Fee H. Goepfert M.E. Johns E.W. Strong P.H. Ward Head and neck cancer first ed. 1990 Marcel Dekker Toronto 279 281
38. J. Bourhis, and F. Mornex The biological basis for chemoradiation F. Mornex J.J. Mazeron J.P. Droz M. Marty Concomitant chemoradiation: current status and future 1999 Editions Scientifiques et médicales Elsevier SAS Paris 16 25
39. J. Bernier, and S.M. Bentzen Altered fraction and radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology Eur J Cancer 39 2003 560 571
40. J.C. Horiot, P. Bontemps, and W. Van den Bogaert Accelerated fractionation (AF) compared with conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial Radiother Oncol 44 1997 111 121
41. A.C. Begg Cisplatin and radiation: interaction probabilities and therapeutic possibilities Int J Radiat Oncol Biol Phys 19 1990 1183 1189
42. E.T. Creagan, K.S. Fountain, S. Frytak, L.W. DeSanto, and J.D. Earle Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancer Med Pediatr Oncol 9 1981 119 120
43. J.W. Denham, and R.L. Abbott Concurrent cisplatin, infusional 5-fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer: dose limiting mucosal toxicity J Clin Oncol 9 1991 458 463
44. B. Leipzig Cisplatin sensitization to radiotherapy of squamous cell carcinomas of the head and neck Am J Surg 146 1983 462 465
45. V.A. Marcial, T.F. Pajak, and M. Mohiuddin Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck: long-term results of the RTOG study 81-17 Cancer 66 1990 1861 1868
46. R.P. Morton, F. Rugman, and P.M. Stell Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomized factorial phase III controlled trial Cancer Chemother Pharmacol 15 1985 283 289
47. Liverpool Head and Neck Oncology Group A phase III randomized trial with cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck Br J Cancer 61 1990 311 315
48. A.A. Forastiere, B. Metch, and D.E. Schuller Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study J Clin Oncol 10 1992 1245 1251
49. S.E. Vogl, D.A. Schoenfeld, B.H. Kaplan, H.J. Lerner, P.F. Engstrom, and J.A. Horton randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer Cancer 56 1985 432 442
50. J.M. Bachaud, E. Cohen-Jonathan, and C. Alzieu Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial Int J Radiat Oncol Biol Phys 36 1996 999 1004
51. J. Weissberg, Y. Son, and R. Papac Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer Int J Radiat Oncol Biol Phys 17 1989 3 9
52. J.M. Bachaud, J.M. David, G. Boussin, and N. Daly Combined post-operative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial Int J Radiat Oncol Biol Phys 20 1991 243 246
53. M. Weissler, S. Melin, and S. Sailer Simultaneous Chemo-radiation in the treatment of advanced head and neck cancer Arch Otolaryngol Head Neck Surg 118 1992 806 810
54. B. Haffty, Y. Son, C. Sasaki, and R. Fisher Mitomycin C as an adjunct to post-operative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials Int J Radiat Oncol Biol Phys 27 1993 241 250
55. M. Al-Sarraf, T.F. Pajak, and R.W. Byhardt Post-operative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24 Int J Radiat Oncol Biol Phys 37 1997 777 782
56. L.J. Peters, H. Goepfert, and K.K. Ang Evaluation of the dose for post-operative radiation therapy of head and neck cancer: first report of a prospective randomized trial Int J Radiat Oncol Biol Phys 26 1993 3 11
57. P.B. Schiff, L.B. Harrison, and E.W. Strong Impact of the time interval between surgery and post-operative radiation therapy on locoregional control in advanced head and neck cancer J Surg Oncol 43 1990 203 208
58. K.K. Ang, A. Trotti, and B.W. Brown Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 51 2001 571 578
59. D.I. Rosenthal, L. Liu, and J.H. Lee Importance of the treatment package time in surgery and post-operative radiation therapy for squamous carcinoma of the head and neck Head Neck 24 2002 115 126
60. G. Sanguineti, R. Corvo', and V. Vitale Post-operative radiotherapy for head and neck squamous cell carcinomas: feasibility of a biphasic accelerated treatment schedule Int J Radiat Oncol Biol Phys 36 1996 1147 1153
61. A. Trotti, D. Klotch, and J. Endicott Post-operative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial Head Neck 20 1998 119 123
62. N. Shah, M.I. Saunders, and S. Dische A pilot study of post-operative CHART and CHARTWEL in head and neck cancer Clin Oncol 12 2000 392 396
63. H.K. Awwad, M. Lotayef, and T. Shouman Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the post-operative radiotherapy of locally advanced head and neck cancer: influence of proliferation Br J Cancer 86 2002 517 523
64. L.J. Peters, and H.R. Withers Applying radiobiological principles to combined modality treatment of head and neck cancer. The time factor Int J Radiat Oncol Biol Phys 39 1997 831 836
65. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086
66. F. Denis, P. Garaud, and E. Bardet Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems Int J Radiat Oncol Biol Phys 55 2003 93 98
67. G. Calais, E. Bardet, and C. Sire Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial Int J Radiat Oncol Biol Phys 58 2004 161 166
68. J. Bernier, C. Domenge, and F. Eschwege Chemo-radiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: results of EORTC phase III trial 22931 Int J Rad Oncol Biol Phys 51 Suppl. 1 2001 1 (Abstract)
69. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiochemotherapy in high-risk SCCA of the head and neck: initial report of RTOG 9501/intergroup phase III trial J Clin Oncol 21 2002 226a (Abstract)
70. K.S. Chao, G. Ozygit, and W.L. Thorsdad Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine Semin Oncol 30 2003 101 108
71. E. Bardet, L. Martin, and G. Calais Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy Semin Oncol 29 2002 57 60
72. J. Bourhis Proc ASCO Annu Meet 489s 2004 5505